In Regard to Thomson et al

Affiliations

¹ Department of Radiation Oncology, Tata Memorial Centre, HBNI, Mumbai, India.
² Department of Epidemiology and Public Health and of Radiation Oncology, University of Maryland School of Medicine, Baltimore, Maryland.

Comment

Tejpal Gupta et al. Int J Radiat Oncol Biol Phys. 2020.

. 2020 Jul 15;107(4):853-854.

doi: 10.1016/j.ijrobp.2020.04.031. Epub 2020 May 13.

¹ Department of Radiation Oncology, Tata Memorial Centre, HBNI, Mumbai, India.
² Department of Epidemiology and Public Health and of Radiation Oncology, University of Maryland School of Medicine, Baltimore, Maryland.

No abstract available

Comment in

In Reply to Gupta et al.
Thomson DJ, Yom SS. Thomson DJ, et al. Int J Radiat Oncol Biol Phys. 2020 Jul 15;107(4):854. doi: 10.1016/j.ijrobp.2020.04.032. Epub 2020 May 13. Int J Radiat Oncol Biol Phys. 2020. PMID: 32589992 Free PMC article. No abstract available.

Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus Statement.
Thomson DJ, Palma D, Guckenberger M, Balermpas P, Beitler JJ, Blanchard P, Brizel D, Budach W, Caudell J, Corry J, Corvo R, Evans M, Garden AS, Giralt J, Gregoire V, Harari PM, Harrington K, Hitchcock YJ, Johansen J, Kaanders J, Koyfman S, Langendijk JA, Le QT, Lee N, Margalit D, Mierzwa M, Porceddu S, Soong YL, Sun Y, Thariat J, Waldron J, Yom SS. Thomson DJ, et al. Int J Radiat Oncol Biol Phys. 2020 Jul 15;107(4):618-627. doi: 10.1016/j.ijrobp.2020.04.016. Epub 2020 Apr 14. Int J Radiat Oncol Biol Phys. 2020. PMID: 32302681 Free PMC article.
Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: An ASTRO-ESTRO consensus statement.
Thomson DJ, Palma D, Guckenberger M, Balermpas P, Beitler JJ, Blanchard P, Brizel D, Budach W, Caudell J, Corry J, Corvo R, Evans M, Garden AS, Giralt J, Gregoire V, Harari PM, Harrington K, Hitchcock YJ, Johansen J, Kaanders J, Koyfman S, Langendijk JA, Le QT, Lee N, Margalit D, Mierzwa M, Porceddu S, Soong YL, Sun Y, Thariat J, Waldron J, Yom SS. Thomson DJ, et al. Radiother Oncol. 2020 Oct;151:314-321. doi: 10.1016/j.radonc.2020.04.019. Epub 2020 Jul 27. Radiother Oncol. 2020. PMID: 32730830 Free PMC article.

1. Thomson D.J., Palma D., Guckenberger M. Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: An ASTRO-ESTRO consensus statement [e-pub ahead of print] Int J Radiat Oncol Biol Phys. 2020 doi: 10.1016/j.ijrobp.2020.04.016. Accessed April 14, 2020. - DOI - PMC - PubMed
1. Covelas A.D., Yom S.S., Pfister D.G. NCCN guidelines insights: Head and neck cancer version 1.2018. J Natl Compr Canc Netw. 2018;16:479–490. - PubMed
1. Bauml J.M., Vinnakota R., Park Y.H.A. Cisplatin every 3 weeks versus weekly with definitive concurrent radiotherapy for squamous cell carcinoma of the head and neck. J Natl Cancer Instit. 2019;111:490–497. - PMC - PubMed
1. Sanghera P., McConkey C., Ho K.F. Hypofractionated-accelerated radiotherapy with concurrent chemotherapy for locally advanced squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 2007;67:1342–1351. - PubMed
1. Chan A.K., Sanghera P., Choo B.A. Hypofractionated accelerated radiotherapy with concurrent carboplatin for locally advanced squamous cell carcinoma of the head and neck. Clin Oncol (R Coll Radiol) 2011;23:34–39. - PubMed